Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-06-18 16:12:43 ET · period of report 2026-06-17 · accession 0001628280-26-044290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 16:12 | 2026-06-17 | MDGL | Brennan Daniel J. | Dir | A - Grant | $0.00 | +404 | 1,371 | +42% | $0 |
| D | 2026-06-18 16:12 | 2026-06-17 | MDGL | Brennan Daniel J. | Dir | A - Grant | $0.00 | +681 | 681 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-17 | A | A | 404 | $0.00 | 1,371 | D | — | — | (F1) Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-17 | A | A | 681 | $0.00 | 681 | D | $499.86 · — to 2036-06-17 | 681 Common Stock | (F2) The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date. |